Simposio: Institutional Corruption and Pharmaceutical Policy

Acceso libre al texto completo de los artículos.

Institutional Corruption and Pharmaceutical Policy
An Edmond J. Safra Center Symposium
(forthcoming)
Journal of Law, Medicine and Ethics
Vol. 14, No. 3 (2013)

• Marc Rodwin, Institutional Corruption and Pharmaceutical Policy
• Lawrence Lessig, Foreword: ‘Institutional Corruption’ Defined
• Gregg Fields, Parallel Problems: Applying Institutional Corruption Analysis of Congress to Big Pharma
  

1. SYSTEMIC PROBLEMS

• Paul D. Jorgensen, Pharmaceuticals, Political Money, and Public Policy: A Theoretical and Empirical Agenda
• Marc-André Gagnon, Corruption of Pharmaceutical Markets: Addressing the Misalignment of Financial Incentives and Public Health
• Marc A. Rodwin, Five Un-Easy Pieces of Pharmaceutical Policy Reform
• Donald W. Light, Joel Lexchin, Jonathan J. Darrow, Institutional Corruption of Pharmaceuticals and the Myth of Safe and Effective Drugs
• Jennifer E. Miller, From Bad Pharma to Good Pharma: Aligning Market Forces with Good and Trustworthy Practices Through Accreditation, Certification, and Rating

2. MEDICAL RESEARCH

• Abigail B. Brown, Understanding Pharmaceutical Research Manipulation in the Context of Accounting Manipulation
• Yuval Feldman, Rebecca L. Gauthier, and Troy H. Schuler, Curbing Misconduct in the Pharmaceutical Industry: Insights from Behavioral Ethics and the Behavioral Approach to Law
• Garry C. Gray, The Ethics of Pharmaceutical Research Funding: A Social Organization Approach

3. MEDICAL KNOWLEDGE AND PRACTICE

• Sergio Sismondo, Key Opinion Leaders and the Corruption of Medical Knowledge: What the Sunshine Act Will and Won’t Cast Light On
• Lisa Cosgrove and Emily E. Wheeler, Drug Firms, the Codification of Diagnostic Categories, and Bias in Clinical Guidelines
• Marc A. Rodwin, Rooting Out Institutional Corruption to Manage Inappropriate Off-Label Drug Use

4. MARKETING

• Sunita Sah and Adriane Fugh-Berman, Physicians Under the Influence: Social Psychology and Industry Marketing Strategies
• Amy Snow Landa and Carl Elliott, From Community to Commodity: The Ethics of Pharma-Funded Social Networking Sites for Physicians

5. PATIENT ADVOCATES

• Susannah L. Rose, Patient Advocacy Organizations: Institutional Conflicts of Interest, Trust, and Trustworthiness